Search
Phio Pharmaceuticals Corp
PHIOAdd to Watchlist
1.040USD
0.0000.00%
Close 07-27 16:00（ET）Quotes delayed by 15 min
12.08MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Phio Pharmaceuticals Corp is 8.00, ranking 168 out of 386 in the Biotechnology & Medical Research industry. The average price target is 14.00, with a high of 14.00 and a low of 14.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
14.000
Target Price
+1246.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Phio Pharmaceuticals Corp
PHIO
1
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Phio Pharmaceuticals Corp's price target?
Analysts forecast that Phio Pharmaceuticals Corp's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
How have Phio Pharmaceuticals CorpPHIO's recent earnings per share performed?
The market expectation was USD -0.34, while Phio Pharmaceuticals CorpPHIO's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD -0.36.
What is the analyst rating for Phio Pharmaceuticals Corp?
Based on the ratings of Phio Pharmaceuticals Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.